As erythrocythemia can be secondarily caused by increased EPO levels [18], we measured the serum EPO levels in Lrfn2 KO mice (Fig 3A) and found that it was significantly decreased (- 6.7%, P = 0.022). The gene discussed is LRFN2; the disease is polycythemia.